Tradestie Institutional Equity Comparison Engine

VTYX vs PHAR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

PHAR Overall Edge

PHAR Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Pharming Group N.V. ADS, each representing 10 ordinary shares (PHAR) driven by superior Valuation, Growth & Margin while VTYX counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, VTYX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus PHAR at N/M Forward P/E and 12.8% operating margin (+20.8% YoY). In options structure, VTYX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PHAR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PHAR
VTYX N/M vs PHAR N/M Fwd P/E
Growth & Margin Winner PHAR
Op Margin 0.0% vs 12.8% ยท YoY +0.0% vs +20.8%
Momentum & Technical Winner VTYX
1Y +786.1% vs -28.6% ยท 52W Pos 55% vs 28%
Options & Structure Winner VTYX
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
VTYX NASDAQ
Ventyx Biosciences, Inc. Common Stock
Pharmaceutical Preparations
$14.00
+0.14% 1D
Market Cap $1.0B
1M Return +0.36%
1Y Return +786.08%
Forward P/E N/M
Unified AI Score
50.4 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 69.0 Mom 40.0
PHAR NASDAQ
Pharming Group N.V. ADS, each representing 10 ordinary shares
Pharmaceutical Preparations
$12.58
-0.16% 1D
Market Cap $891.8M
1M Return +34.4%
1Y Return -28.6%
Forward P/E N/M
Unified AI Score
36.2 / 100 SELL
Tech 27.0 Fund 30.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VTYX +786.08% PHAR -28.6% Spread: +59.2 pp (VTYX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
VTYX TTM Op. Margin: 0.0% PHAR TTM Op. Margin: 12.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VTYX vs PHAR. Trailing 12-month operating profitability (VTYX 0.0% vs PHAR 12.8%) and valuation multiples (VTYX N/M vs PHAR N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VTYX (4) vs PHAR (5)
Institutional Metric VTYX PHAR Criterion Row Winner
Market Capitalization Scale $1.0B $891.8M Larger Scale VTYX
Trailing P/E Ratio Valuation N/M 39.4x Lower Multiple PHAR
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +20.8% Higher Growth PHAR
Operating Margin (TTM) Profitability 0.0% 12.8% Higher Margin PHAR
Net Profit Margin Profitability 0.0% 6.2% Higher Margin PHAR
Return on Equity (ROE) Capital Efficiency -45.4% 8.7% Higher ROE PHAR
52-Week Range Position Momentum 55% ($1โ€“$25) 28% ($9โ€“$21) Stronger Trend VTYX
Beta / 30D Volatility Risk Regime 2.07ฮฒ ยท 2% Vol 0.83ฮฒ ยท 60% Vol Lower Realized Risk VTYX
Unified Institutional Score Composite Signal 50.4 / 100 (HOLD) 36.2 / 100 (SELL) Higher Composite VTYX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VTYX vs PHAR Buy Guide
VTYX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live VTYX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PHAR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PHAR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VTYX nor PHAR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.